|
|
Improved Efficacy with Response and MRD-guided Ibrutinib–Obinutuzumab (IO) Intensification |
|
23 January |
10:45
11:00
|
SC Papendal
Room 8/9
|
|
|
|
Lenalidomide with or without ESA in low risk MDS |
Speaker:
Arjan van de Loosdrecht |
23 January |
11:00
11:15
|
SC Papendal
Room 8/9
|
|
|
|
One test to measure them all! |
|
23 January |
11:15
11:30
|
SC Papendal
Room 8/9
|
|
|
|
Treatment and outcome among patients with BPDCN in the Netherlands |
|
23 January |
11:30
11:45
|
SC Papendal
Room 8/9
|
|
|
|
Patient-reported outcomes among patients treated with CAR T-cell therapy or bispecifics |
|
23 January |
11:45
12:00
|
SC Papendal
Room 8/9
|
|
|
|
RODEO: Prospective Multicenter Study on Patient-Guided TKI Dose Reduction in CML |
|
23 January |
12:00
12:15
|
SC Papendal
Room 8/9
|
|
